Form D · Pharmaceuticals
Eldec Pharmaceuticals, Inc.
Chapel Hill, NC · CIK 0002110508
Offering snapshot reported Feb 12, 2026 · SEC filing
- Reported sold
- $200K Offering amount: $1.5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 11, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 12, 2026 | Initial | $200,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-573386
Source: Form D, filed Feb 12, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Schotzinger | Director, Executive |
| Robert Tarran | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
510 Meadowmont Village Circle Suite 364
Chapel Hill, NC, 27517
Phone: (919) 219-1113
Chapel Hill, NC, 27517
Phone: (919) 219-1113